{Reference Type}: Editorial
{Title}: Feasibility and limitations of combined treatment for lateral pelvic lymph node metastases in rectal cancer.
{Author}: Zheng YZ;Yan FF;Luo LX;
{Journal}: World J Clin Oncol
{Volume}: 15
{Issue}: 5
{Year}: 2024 May 24
暂无{DOI}: 10.5306/wjco.v15.i5.591
{Abstract}: Colorectal cancer ranks among the most commonly diagnosed cancers globally, and is associated with a high rate of pelvic recurrence after surgery. In efforts to mitigate recurrence, pelvic lymph node dissection (PLND) is commonly advocated as an adjunct to radical surgery. Neoadjuvant chemoradiotherapy (NACRT) is a therapeutic approach employed in managing locally advanced rectal cancer, and has been found to increase the survival rates. Chua et al have proposed a combination of NACRT with selective PLND for addressing lateral pelvic lymph node metastases in rectal cancer patients, with the aim of reducing recurrence and improving survival outcomes. Nevertheless, certain studies have indicated that the addition of PLND to NACRT and total mesorectal excision did not yield a significant reduction in local recurrence rates or improvement in survival. Consequently, meticulous patient selection and perioperative chemotherapy may prove indispensable in ensuring the efficacy of PLND.